In summary, our study suggests an effect of polymorphisms in the FFAR1 gene on insulin secretion during an OGTT thereby making it a potential candidate to mediate lipotoxicicty in T2D. This evidence concerns the gene FFAR1 and type 2 diabetes mellitus.